Longitudinal evaluation of efficacy, safety and nutritional status during one-year treatment with the duodenal-jejunal bypass liner

Riedel, Nina; Laubner, Katharina; Lautenbach, Anne; Schön, Gerhard; Schlensak, Matthias; Stengel, Rainer; Eberl, Thomas; Dederichs, Frank; Aberle, Jens; Seufert, Jochen

doi:10.1016/j.soard.2018.02.029

Cited by 15Bariatric Surgery and OutcomesMinimally Invasive Surgical TechniquesDiabetes Treatment and Management

Longitudinal evaluation of efficacy, safety and nutritional status during one-year treatment with the duodenal-jejunal bypass liner

Riedel, Nina, Laubner, Katharina, Lautenbach, Anne, Schön, Gerhard, Schlensak, Matthias, Stengel, Rainer, Eberl, Thomas, Dederichs, Frank +2 more·2018·Surgery for Obesity and Related Diseases

DOI 10.1016/j.soard.2018.02.029

Open this paper in CoChat — free account

Abstract

Background The endoscopic duodenal-jejunal bypass liner (DJBL) represents a novel temporary endoscopic approach for treatment of obesity-associated type 2 diabetes. Recent results from the German DJBL registry confirmed substantial positive metabolic effects of the DJBL in type 2 diabetes. However, the last Food and Drug Administration trial was stopped due to a high occurrence of hepatic abscesses (3.5%). Objectives Here, we analyzed time courses of development of co-morbidities, nutritive changes, and occurrence of adverse events during the 1-year treatment phase with the DJBL in the German DJBL registry. Methods Sixty-six patients from the registry were analyzed for efficacy, safety, and nutritional status. Patient data sets were analyzed at implantation, 3 and 6 months after implantation, and at explantation visits. Results Weight, body mass index, glycated hemoglobin, and low-density lipoprotein cholesterol primarily declined during the first 3 months after implantation, whereas systolic and diastolic blood pressure were predominantly reduced during the second half of the treatment phase. Severe DJBL-associated side effects were mainly documented at the explantation visit (intestinal obstruction [1.7%], dislocation [1.7%], and liver abscess [1.7%]). Measurements of serum concentrations of ferritin, albumin, vitamin B12, folic acid, 25-hydroxyvitamin D3 (25 OH-Vit-D3), and calcium provided suggestive evidence of a possible decrease of nutritional absorption of vitamins and trace elements by the DJBL. Conclusions The DJBL demonstrates high efficacy with substantial improvement of all parameters of the metabolic syndrome and the potential for reduction of comedications in overweight patients with type 2 diabetes. These registry results are important to optimize recommendations for adaptation of concomitant medication, surveillance of adverse events, nutritional status and supplementation, and adaptation of the implantation period of the DJBL.

Integrity signals

Registry

Crossref · 10.1016/j.soard.2018.02.029

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

DJBL use is associated with malabsorption-related deficiencies in ferritin, albumin, vitamin B12, and folic acid.
“Notably, DJBL use has been associated with malabsorption-related deficiencies in ferritin, albumin, vitamin B12, and folic acid [104].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [104]

Fitting Linear Mixed-Effects Models Using <b>lme4</b>
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835 · see citing works
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092 · see citing works
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198 · see citing works
Fitting Linear Mixed-Effects Models Using lme4Preprint
Bates, D. M., Maechler, M., Bolker, B. M., & Walker, S. (2014) · arXiv (Cornell University) · doi:10.3929/ethz-b-000105397 · Cited by 9,435 · see citing works
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457 · see citing works
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726 · see citing works
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582 · see citing works
Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline
Heber, D., Greenway, F. L., Kaplan, L. M., Livingston, E., Salvador, J., & Still, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2128 · Cited by 521 · see citing works
Bariatric Surgery for Morbid Obesity
DeMaria, E. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmct067019 · Cited by 427 · see citing works
A systematic review and meta-analysis on the therapeutic equivalence of statins: <i>Therapeutic equivalence of statins</i>
Weng, T.-C., Yang, Y.-H. K., Lin, S.-J., & Tai, S.-H. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2009.01085.x · Cited by 345 · see citing works
A Multicenter, Randomized Efficacy Study of the EndoBarrier Gastrointestinal Liner for Presurgical Weight Loss Prior to Bariatric Surgery
Schouten, R., Rijs, C. S., Bouvy, N. D., Hameeteman, W. M., Koek, G. H., Janssen, I. M. C., & Greve, J.-W. M. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181bdfbff · Cited by 279 · see citing works
Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation
Gasteyger, C., Suter, M., Gaillard, R. C., & Giusti, V. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1128 · Cited by 219 · see citing works
Glycemic Management of Type 2 Diabetes Mellitus
Ismail‐Beigi, F. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1013127 · Cited by 179 · see citing works
Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates
Gersin, K. S., Rothstein, R. I., Rosenthal, R. J., Stefanidis, D., Deal, S. E., Kuwada, T. S., Laycock, W. S., Adrales, G. L., Vassiliou, M., Szomstein, S., et al. (2010) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2009.11.051 · Cited by 177 · see citing works
Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery
Tarnoff, M. E., Rodriguez, L., Escalona, A., RAMOS, A. C., Neto, M. G., Alamo, M., Reyes, E., Pimentel, F., & Ibañez, L. A. (2008) · Surgical Endoscopy · doi:10.1007/s00464-008-0125-4 · Cited by 174 · see citing works
Endoscopic Duodenal–Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes
de Jonge, C., Rensen, S. S., Verdam, F. J., Vincent, R. P., Bloom, S. R., Buurman, W. A., le Roux, C. W., Schaper, N. C., Bouvy, N. D., & Greve, J. W. M. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0921-3 · Cited by 147 · see citing works
Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates
Scolapio, J. S. (2010) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(10)79499-x · Cited by 146 · see citing works
Early Improvement in Glycemic Control After Bariatric Surgery and Its Relationships with Insulin, GLP-1, and Glucagon Secretion in Type 2 Diabetic Patients
Umeda, L. M., Silva, E. A., Carneiro, G., Arasaki, C. H., Geloneze, B., & Zanella, M. T. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0412-3 · Cited by 128 · see citing works
Metabolic Improvements in Obese Type 2 Diabetes Subjects Implanted for 1 Year with an Endoscopically Deployed Duodenal–Jejunal Bypass Liner
de Moura, E. G. H., Martins, B. D. C., Lopes, G. S., Orso, I. R. B., Oliveira, S. L. D., Neto, M. G., Santo, M. A., Sakai, P., RAMOS, A. C., Júnior, A. B. G., et al. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0152 · Cited by 124 · see citing works
Effect of Bariatric Surgery on Hypertension
Wilhelm, S. M., Young, J., & Kale-Pradhan, P. B. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014529260 · Cited by 117 · see citing works
Intragastric balloon for obesity
Fernandes, M. A., Atallah, Á. N., Soares, B. G., Saconato, H., Guimarães, S. M., Matos, D., Monteiro, L. R. C., & Richter, B. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004931.pub2 · Cited by 115 · see citing works
Weight Loss and Metabolic Improvement in Morbidly Obese Subjects Implanted for 1 Year With an Endoscopic Duodenal-Jejunal Bypass Liner
Escalona, A., Pimentel, F., Sharp, A. C., Becerra, P., M, M. S., Turiel, D., Muñoz, R., Claudia Bambs, S., Guzmán, S., Ibañez, L. A., et al. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31825498c4 · Cited by 112 · see citing works
Economic costs of adult obesity: A review of recent European studies with a focus on subgroup-specific costs
von Lengerke, T., & Krauth, C. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.04.005 · Cited by 111 · see citing works
Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data
Jamal, M., Wegner, R. C., Heitshusen, D. S., Liao, J., & Samuel, I. (2010) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2010.08.009 · Cited by 53 · see citing works
Improvement of Insulin Resistance and Reduction of Cardiovascular Risk Among Obese Patients with Type 2 Diabetes with the Duodenojejunal Bypass Liner
de Moura, E. G. H., Orso, I. R. B., Martins, B. D. C., Sauniti, G., Oliveira, S. L. D., Neto, M. G., Mancini, M. C., Santo, M. A., Sakai, P., RAMOS, A. C., et al. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0387-0 · Cited by 50 · see citing works
Future direct and indirect costs of obesity and the influence of gaining weight: Results from the MONICA/KORA cohort studies, 1995–2005
Wolfenstetter, S. B. (2011) · Economics & Human Biology · doi:10.1016/j.ehb.2011.08.008 · Cited by 47 · see citing works
Endoscopic Treatment of Obesity
Swidnicka-Siergiejko, A. K., Wróblewski, E., & Dâbrowski, A. (2011) · Canadian Journal of Gastroenterology · doi:10.1155/2011/174163 · Cited by 34 · see citing works
Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders
Stratmann, B., Krepak, Y., Schiffer, E., Jarick, I., Hauber, M., Lee-Barkey, Y., Fischer, M., & Tschoepe, D. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-115175 · Cited by 23 · see citing works
Positionspapier der Fachgesellschaften zur Anwendungsempfehlung der endoskopischen biliodigestiven Diversion in Deutschland – DDG/DGAV/DGVS –
Siegel, E. G., Kähler, G. F. B. A., & Schepp, W. (2014) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0034-1366570 · Cited by 7 · see citing works

Flagged first, then by citations

Sorted by citations

Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608 · see citing works
Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored By American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society For Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510 · see citing works
Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Mechanick, J. I., Apovian, C. M., Brethauer, S. A., Garvey, W. T., Joffe, A. M., Kim, J. J., Kushner, R. F., Lindquist, R., Pessah‐Pollack, R., Seger, J., et al. (2020) · Obesity · doi:10.1002/oby.22719 · Cited by 410 · see citing works
The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
Ruban, A., Ashrafian, H., & TEARE, J. P. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/7823182 · Cited by 76 · see citing works
Duodenal-Jejunal Bypass Liner (DJBL) Improves Cardiovascular Risk Biomarkers and Predicted 4-Year Risk of Major CV Events in Patients with Type 2 Diabetes and Metabolic Syndrome
Roehlen, N., Laubner, K., Bettinger, D., Schwacha, H., Hilger, H., Koenig, C., Grueninger, D., Krebs, A., & Seufert, J. (2020) · Obesity Surgery · doi:10.1007/s11695-019-04324-2 · Cited by 19 · see citing works
Self-citation
Impact of duodenal-jejunal bypass liner (DJBL) on NAFLD in patients with obesity and type 2 diabetes mellitus
Roehlen, N., Laubner, K., Nicolaus, L., Schwacha, H., Bettinger, D., Krebs, A., Thimme, R., & Seufert, J. (2022) · Nutrition · doi:10.1016/j.nut.2022.111806 · Cited by 17 · see citing works
Self-citation
Nanoparticles mediated folic acid enrichment
Mishra, V. K., Rodriguez-Lecompte, J. C., & Ahmed, M. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.139964 · Cited by 15 · see citing works
Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
Tasabehji, D., Saleh, S., & Mokadem, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124012 · Cited by 14 · see citing works
A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT
Ruban, A., Glaysher, M., Miras, A., Goldstone, A., Prechtl, C., Johnson, N., Li, J. V., Aldhwayan, M. M., Aldubaikhi, G., Glover, B., et al. (2020) · Efficacy and Mechanism Evaluation · doi:10.3310/eme07060 · Cited by 13 · see citing works
Duodenal–jejunal bypass liners are superior to optimal medical management in ameliorating metabolic dysfunction: A systematic review and meta‐analysis
McLennan, S., Verhoeff, K. K., Purich, K., Dang, J. T., Kung, J. Y. C., & Mocanu, V. (2023) · Obesity Reviews · doi:10.1111/obr.13572 · Cited by 4 · see citing works
New Anchoring Mechanism and Design of an Endoluminal Duodeno-Jejunal Bypass Liner for Treatment of Obesity: a Pilot Animal Trial
Frydenberg, H., Suturin, V. M., Truong, H., Ryan, A. M., & Soutorine, M. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03945-x · Cited by 3 · see citing works
Is duodeno-jejunal bypass liner superior to pylorus preserving bariatric surgery in terms of complications and efficacy?
Balint, I. B., Császár, F., Somodi, K., Ternyik, L., Bíró, A., & Káposztás, Z. (2021) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-021-02131-x · Cited by 3 · see citing works
Gastroenterology
Pandey, S., & Navaneeethabalakrishnan, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820728-4.00007-1 · Cited by 1 · see citing works
The role of duodenal jejunal bypass liner in obesity treatment
Ülger, T. G., Tayfur, M., Çakiroğlu, F. P., & Özcan, Ç. (2021) · AIMS Medical Science · doi:10.3934/medsci.2021019
Application of Endoscopic Duodenal-Jejunal Bypass Sleeve in the Treatment of Obesity Combined with Type 2 Diabetes Mellitus
韩, 额. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.143700

Efficacy and safety development and nutritive changes during one-year treatment with the duodenal-jejunal bypass liner (DJBL)
Riedel, N., Laubner, K., Lautenbach, A., Gijbels, P., Stengel, R., Eberl, T., Dederichs, F., Aberle, J., & Seufert, J. (2017) · Diabetologie und Stoffwechsel · doi:10.1055/s-0037-1601680
Self-citation
Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial.
Ruban, A., Miras, A. D., Glaysher, M. A., Goldstone, A. P., Prechtl, C. G., Johnson, N. A., Chhina, N., Al‐Najim, W., Aldhwayan, M., Klimowska‐Nassar, N., et al. (2022) · PubMed Central · doi:10.1097/sla.0000000000004980 · Cited by 20 · see citing works
Efficacy and safety of duodenal–jejunal bypass liner for obesity and type 2 diabetes: A systematic review and meta‐analysis
Chen, W., Feng, J., Dong, S., Guo, J., Zhou, F., Hu, S., Hu, R., Wang, C., Ma, Y., & Dong, Z. (2024) · Obesity Reviews · doi:10.1111/obr.13812 · Cited by 8 · see citing works
Comparative efficacy and safety of the duodenal‐jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study
Laubner, K., Riedel, N., Fink, K., Holl, R. W., Welp, R., Kempe, H., Lautenbach, A., Schlensak, M., Stengel, R., Eberl, T., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13300 · Cited by 24 · see citing works
Self-citation
Safety and efficacy of the duodenal-jejunal bypass liner for treatment of obesity and diabetes
Betzel, B. (2019) · Radboud Repository (Radboud University)

Authors: Riedel, N., Laubner, K., Lautenbach, A., Schön, G., Schlensak, M., Stengel, R., Eberl, T., Dederichs, F., Aberle, J., & Seufert, J.
Affiliations: University Medical Center Hamburg-Eppendorf (DE)
University of Freiburg (DE)
Emschergenossenschaft (DE)
Marienhospital Gelsenkirchen (DE)
Corresponding author: Riedel, Nina
ORCID: Riedel, Nina
Laubner, Katharina
Lautenbach, Anne
Schön, Gerhard
Aberle, Jens
Seufert, Jochen
Venue: Surgery for Obesity and Related Diseases
Publisher: Elsevier BV
Published: 2018-06
Volume: 14
Issue: 6
Pages: 769-779
ISSN: 1550-7289 (ISSN-L)
DOI: 10.1016/j.soard.2018.02.029
OpenAlex: W2790718648
Cited by: 15
References: 30
Citations by year: 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 1
FWCI: 2.62
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Surgery for Obesity and Related Diseases (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: duodenal-jejunal bypass liner, endoscopic obesity treatment
MeSH terms: Blood Pressure, Diabetes Mellitus, Type 2, Duodenum, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Jejunum, Cholesterol, LDL, Longitudinal Studies, Male, Middle Aged, Nutritional Status, Obesity, Morbid, Postoperative Complications, Registries, Abdominal Pain, Body Mass Index, Endoscopy, Gastrointestinal, Treatment Outcome, Prostheses and Implants, Bariatric Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Longitudinal evaluation of efficacy, safety and nutritional status during one-year treatment with the duodenal-jejunal bypass liner

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks